JP2024535691A5 - - Google Patents

Info

Publication number
JP2024535691A5
JP2024535691A5 JP2024509394A JP2024509394A JP2024535691A5 JP 2024535691 A5 JP2024535691 A5 JP 2024535691A5 JP 2024509394 A JP2024509394 A JP 2024509394A JP 2024509394 A JP2024509394 A JP 2024509394A JP 2024535691 A5 JP2024535691 A5 JP 2024535691A5
Authority
JP
Japan
Prior art keywords
ryk
seq
cdr
antibody
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024509394A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024535691A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/075147 external-priority patent/WO2023023600A1/en
Publication of JP2024535691A publication Critical patent/JP2024535691A/ja
Publication of JP2024535691A5 publication Critical patent/JP2024535691A5/ja
Pending legal-status Critical Current

Links

JP2024509394A 2021-08-18 2022-08-18 抗受容体チロシンキナーゼ関連タンパク質（Ｒｙｋ）抗体及びその使用 Pending JP2024535691A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163234527P 2021-08-18 2021-08-18
US63/234,527 2021-08-18
PCT/US2022/075147 WO2023023600A1 (en) 2021-08-18 2022-08-18 Anti-related-to-receptor tyrosine kinase (ryk) antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2024535691A JP2024535691A (ja) 2024-10-02
JP2024535691A5 true JP2024535691A5 (https=) 2025-08-26

Family

ID=85241071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024509394A Pending JP2024535691A (ja) 2021-08-18 2022-08-18 抗受容体チロシンキナーゼ関連タンパク質（Ｒｙｋ）抗体及びその使用

Country Status (11)

Country Link
US (1) US20250027945A1 (https=)
EP (1) EP4387669A4 (https=)
JP (1) JP2024535691A (https=)
KR (1) KR20240046558A (https=)
CN (1) CN117979997A (https=)
AU (1) AU2022331476A1 (https=)
CA (1) CA3229528A1 (https=)
IL (1) IL310670A (https=)
MX (1) MX2024001979A (https=)
TW (1) TW202315894A (https=)
WO (1) WO2023023600A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028424A1 (es) * 2000-05-10 2003-05-07 Bayer Corp Metodo para regular la angiogenesis utilizando proteina ryk
AU2003239248A1 (en) * 2002-06-07 2003-12-22 The Government Of The United States, As Represented By The Secretary Of The Department Of Health And Anti-cd30 stalk and anti-cd30 antibodies suitable for use in immunotoxins
CA2694055A1 (en) * 2007-08-01 2009-02-05 Glaxo Group Limited Novel antibodies
WO2017172733A1 (en) * 2016-03-28 2017-10-05 The Regents Of The University Of California Anti-ryk antibodies and methods of using the same

Similar Documents

Publication Publication Date Title
CN111944050B (zh) 一种抗b7-h3抗体及其应用
CN110799539B (zh) 抗4-1bb抗体及其制备和使用方法
KR102593409B1 (ko) Her3 항원 결합 분자
CN113874399B (zh) 抗ror1/抗cd3双特异性结合分子
JP2023517753A5 (https=)
WO2021249542A1 (en) Antibodies binding tnfr2 and uses thereof
KR20230079409A (ko) 항-cd3 항체 및 이의 용도
JP7720989B2 (ja) Ｅｇｆｒ及びｈｅｒ３を標的とする二重特異性四価抗体
KR20250152073A (ko) 항체, 항원 결합 단편 및 사용 방법
US20200131263A1 (en) Anti-gitr antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
JP2024509501A5 (https=)
WO2023246247A1 (zh) 药物组合物及其用途
WO2025261506A1 (zh) 抗Nectin-4抗体以及其用途
JP7848412B2 (ja) Ｔｒｏｐ２結合剤およびそのコンジュゲート
JP2024535691A5 (https=)
WO2023221935A1 (zh) 结合pd-l1和cldn18.2的抗体及其用途
WO2024077547A1 (zh) 一种b7h3/pdl1双特异性抗体及其药物组合物及应用
IL310684A (en) Membrane with biodegradable polymer
WO2024088386A1 (en) Antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
WO2025131054A1 (en) Antibody drug conjugates targeting to b7-h3 and egfr and the use thereof
KR20250069411A (ko) 항 ceacam5 항체 및 이의 용도
TW202540198A (zh) 雙特異性抗體樣蛋白以及彼之製造及使用方法
IL310670A (en) Anti-related-to-receptor tyrosine kinase (ryk) antibodies and uses thereof
KR20250116579A (ko) Gpc3에 특이적으로 결합하는 신규 항체 및 이의 용도
WO2025201493A1 (zh) Dll3结合分子及其用途